Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference

1.Lonial S, Weiss BM, Usmani SZ, et al. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial. Lancet 2016;387:1551–60.10.1016/S0140-6736(15)01120-4Search in Google Scholar

2.De Vooght KMK, Oostendorp M, Van Solinge WW. New mAb therapies in multiple myeloma: interference with blood transfusion compatibility testing. Curr Opin Hematol 2016;23:557–62.10.1097/MOH.000000000000027627389485Search in Google Scholar

3.Chapuy CI, Nicholson RT, Aguad MD, et al. Resolving the daratumumab interference with blood compatibility testing. Transfusion 2015;55:1545–54.10.1111/trf.1306925764134Search in Google Scholar

4.van de Donk NW, Moreau P, Plesner T, et al. Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma. Blood 2016;127:681–96.10.1182/blood-2015-10-64681026631114Search in Google Scholar

5.Mehta K, Shahid U. CD38: a cell-surface protein with multiple functions. FASEB J 1996;10:1408–17.10.1096/fasebj.10.12.89035118903511Search in Google Scholar

6.AABB Association Bulletin #16-02 Mitigating the Anti-CD38 Interference with Serologic Testing. 2016. Available from https://www.aabb.org/programs/publications/bulletins/Documents/ab16-02.pdf.Search in Google Scholar

7.Chapuy CI, Aguad MD, Nicholson RT, et al. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion 2016;12: 2964–72.10.1111/trf.1378927600566Search in Google Scholar

8.Cooling L, Downs T. Immunohematology. In: Hutchinson R, McPherson R, Schexneider K, eds. Henry’s clinical diagnosis and management by laboratory methods. 22nd ed. Philadelphia, PA: Elsevier Saunders 2011:674–730.10.1016/B978-1-4377-0974-2.00035-XSearch in Google Scholar

9.Schmidt AE, Kirkley S, Patel N, et al. An alternative method to dithiothreitol treatment for antibody screening in patients receiving daratumumab. Transfusion 2015;55:2292–3.10.1111/trf.1317426372917Search in Google Scholar

10.Fung MK, Grossman BJ, Hillyer CD, Westhoff CM, eds. Technical manual. 18th ed. Bethesda, MD: AABB, 2014.Search in Google Scholar